These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis]. Dahlström U; Alehagen U Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036 [No Abstract] [Full Text] [Related]
27. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure]. Rutten JH; Boomsma F; Van den Meiracker AH Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722 [TBL] [Abstract][Full Text] [Related]
28. Biomarkers in heart failure. Does prognostic utility translate to clinical futility? Maisel A J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715 [No Abstract] [Full Text] [Related]
30. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? Rodeheffer RJ J Am Coll Cardiol; 2004 Aug; 44(4):740-9. PubMed ID: 15312852 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN; J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480 [TBL] [Abstract][Full Text] [Related]
32. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine. Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109 [TBL] [Abstract][Full Text] [Related]
35. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure. Cortés R; Rivera M; Salvador A; García de Burgos F; Bertomeu V; Roselló-Lletí E; Martínez-Dolz L; Payá R; Almenar L; Portolés M J Card Fail; 2007 Sep; 13(7):549-55. PubMed ID: 17826645 [TBL] [Abstract][Full Text] [Related]
36. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients]. Shao YH; Lai YQ; Lin AZ; Kong YZ Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094 [TBL] [Abstract][Full Text] [Related]
37. B-type natriuretic peptide assays for detecting heart failure in the elderly: same value as those in the younger? Rutten FH; Hoes AW Int J Cardiol; 2008 Apr; 125(2):161-5. PubMed ID: 17963872 [TBL] [Abstract][Full Text] [Related]
38. Serial measurements of plasma B-type natriuretic peptides: what do they tell us? Richards AM J Am Coll Cardiol; 2008 Sep; 52(12):1004-5. PubMed ID: 18786481 [No Abstract] [Full Text] [Related]
39. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment. Richards M; Troughton R; Lainchbury J; Doughty R; Wright S Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970 [TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptides: applications for heart failure management in 2005. Troughton RW; Richards M Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]